跳至主要内容
临床试验/NCT02186925
NCT02186925招募中不适用

A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.

Meir Medical Center1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
Progression Free Survival

研究概览

简要总结

Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age.

排除标准

  • Patients under the age of 18

结局指标

主要结局

Progression Free Survival

时间窗: 5 years

Univariate analysis will be used to assess the effects of clinical factors on progression free survival.

次要结局

  • Patient overall survival(5 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验